Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
-
Gene therapy for brain tumors: Long-Term safety under the microscope
Disease control ENROLLING_BY_INVITATIONThis study follows 100 people with vestibular schwannoma (a non-cancerous brain tumor) who previously received a gene therapy called AAVAnc80-antiVEGF. Researchers will monitor participants for years to check for late side effects and measure any changes in tumor size using MRI s…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Gene therapy for deafness: Long-Term safety check begins
Disease control ENROLLING_BY_INVITATIONThis study follows 30 people who previously received a gene therapy called AAVAnc80-hOTOF for hearing loss caused by otoferlin gene mutations. Researchers will monitor participants for several years to check for late side effects and measure how well the treatment preserves or im…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC